A negative scan does not always mean recurrent prostate cancer is nowhere to be found. Sometimes, the disease may simply be ...

Research presented this week at the Alzheimer’s Association International Conference in London suggests that the use of blood ...

One of the biggest challenges in cancer research has been linking the "big picture" seen in medical scans with the ...

It’s 2017 and I’m working as a barrister on a very challenging case in Liverpool: a four-handed, cut-throat murder case in ...

"We're at the early stages of having doctors understanding how to utilize these tests and how to move forward." ...

A second scan using prostate-specific membrane antigen positron emission tomography changed treatment plans for nearly half of patients with recurrent prostate cancer whose initial scan was negative, ...

They’ve been a constant companion, a confidant and walking buddy, a bed hog, best friend and a comfort during life’s storms, ...

Blood tests for tau, a key biomarker of Alzheimer’s disease, may predict dementia risk, a new study found. How best to use ...

Alzheimer's blood test p-tau217 predicts 78% cognitive decline risk within ten years in symptom-free older adults, a JAMA ...

Led by experts from the Mass General Brigham Neuroscience Institute, the study demonstrates that a blood test can predict the ...

A study presented at the American Society of Clinical Oncology (ASCO) annual meeting suggested that circulating tumor (ct)DNA ...

An Alzheimer’s drug could prevent dementia before symptoms show, with research suggesting it could clear toxic brain plaques ...